Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The National Institute of Health Research (NIHR) awarded £4 million to enable state-of-the-art psychological therapy to be delivered via virtual reality (VR) in the NHS, in a project that brings together a team of NHS trusts, universities, a mental health charity, the Royal College of Art, and a University of Oxford spin-out company.

Image courtesy of Oxford VR

'Our project will see one of the most exciting and powerful new technologies implemented in the NHS for the first time” said the project lead, Professor Daniel Freeman from Oxford University’s Department of Psychiatry.

'Virtual reality treatment can help patients transform their lives. When people put on our headsets, a virtual coach takes them into computer-generated simulations of the situations they find troubling.

'The coach guides the patient through these scenarios, helping them practise techniques to overcome their difficulties. Patients often find it easier to do this work in the virtual world – and they enjoy using our VR applications – but the beauty is that the benefits transfer to the real world,' said Professor Freeman, who is also a clinical psychologist at Oxford Health NHS Foundation Trust.

Find out more (University of Oxford website)

Find out more (Department of Psychiatry website)

Similar stories

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.

Significant scale-up investment for three Oxford spinouts

Three University of Oxford spinouts have raised significant investment to scale their companies in vehicle automation, quantum computing and medical imaging respectively.

Oxford Innovation Society celebrates pioneering biomedical research and innovation

Last month the Oxford Innovation Society (OIS) hosted an event at Pembroke College which celebrated some of the pioneering translational research and innovation coming out of the University’s Medical Sciences Division.

Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology

Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.

Oxford spinout MiroBio acquired by Gilead Sciences for $405m

The inflammatory diseases company’s rapid ascent and exit underscores the importance of friendships, partnerships and networks in innovation.

Oxford to receive £7 million to turn bright ideas into global opportunities

The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from UK research institutions.